Literature DB >> 23772351

Generating Better Medicines for Cancer.

Stuart S Dunn1, James D Byrne, Jillian L Perry, Kai Chen, Joseph M Desimone.   

Abstract

The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges faced by cancer therapies. The versatility of the PRINT® (Particle Replication In Non-wetting Templates) process has enabled the preparation of shape- and size-specific particles with a wide range of chemical compositions and therapeutic cargos. Different particle matrices and drugs may be combined in a plug-and-play approach, such that physico-chemical characteristics of delivery vectors may be optimized for biocompatibility, cargo stability and release, circulation half-life, and efficacy. Thus, the engineering of particles for cancer therapy with specific biophysical behaviors and cellular responses has been demonstrated via the PRINT process.

Entities:  

Keywords:  PRINT; cancer; drug delivery; medicine; nanoparticle; soft lithography

Year:  2013        PMID: 23772351      PMCID: PMC3680140          DOI: 10.1021/mz400116a

Source DB:  PubMed          Journal:  ACS Macro Lett            Impact factor:   6.903


  23 in total

1.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Authors:  Warefta Hasan; Kevin Chu; Anuradha Gullapalli; Stuart S Dunn; Elizabeth M Enlow; J Christopher Luft; Shaomin Tian; Mary E Napier; Patrick D Pohlhaus; Jason P Rolland; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-12-21       Impact factor: 11.189

2.  Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells.

Authors:  Robby A Petros; Patricia A Ropp; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2008-03-20       Impact factor: 15.419

3.  Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing.

Authors:  Stuart S Dunn; Shaomin Tian; Steven Blake; Jin Wang; Ashley L Galloway; Andrew Murphy; Patrick D Pohlhaus; Jason P Rolland; Mary E Napier; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2012-04-19       Impact factor: 15.419

4.  Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

Authors:  Elizabeth M Enlow; J Christopher Luft; Mary E Napier; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-01-25       Impact factor: 11.189

Review 5.  Delivering nanomedicine to solid tumors.

Authors:  Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  Nat Rev Clin Oncol       Date:  2010-09-14       Impact factor: 66.675

6.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.

Authors: 
Journal:  Colloids Surf B Biointerfaces       Date:  2000-10-01       Impact factor: 5.268

7.  Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

Authors:  Matthew C Parrott; Mathew Finniss; J Chris Luft; Ashish Pandya; Anuradha Gullapalli; Mary E Napier; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2012-04-30       Impact factor: 15.419

8.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

9.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.

Authors:  Jin Wang; Shaomin Tian; Robby A Petros; Mary E Napier; Joseph M Desimone
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

10.  Does a targeting ligand influence nanoparticle tumor localization or uptake?

Authors:  Kathleen F Pirollo; Esther H Chang
Journal:  Trends Biotechnol       Date:  2008-08-21       Impact factor: 19.536

View more
  2 in total

1.  Nanomanufacturing: A Perspective.

Authors:  J Alexander Liddle; Gregg M Gallatin
Journal:  ACS Nano       Date:  2016-02-22       Impact factor: 15.881

2.  Biodistribution and trafficking of hydrogel nanoparticles in adult mosquitoes.

Authors:  Cynthia C H Paquette; Yashdeep Phanse; Jillian L Perry; Irma Sanchez-Vargas; Paul M Airs; Brendan M Dunphy; Jing Xu; Jonathan O Carlson; J Christopher Luft; Joseph M DeSimone; Lyric C Bartholomay; Barry J Beaty
Journal:  PLoS Negl Trop Dis       Date:  2015-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.